SCHEMBL9664945

SCHEMBL9664945

FC(F)(F)c1nc2ccc(Cn3ccnc3)cc2n1CC1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CYP2B6 P20813 2/20 0.44
CYP19A1 P11511 10/20 0.41
TBXAS1 P24557 2/20 0.39
CYP11B1 P15538 4/20 0.38
CYP11B2 P19099 4/20 0.38
CNR2 P34972 2/20 0.38
CYP17A1 P05093 1/20 0.36
CYP2A6 P11509 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9663726 0.80 CYP11B1 (0.53) CYP19A1TBXAS1CYP11B1CYP11B2CYP17A1
SCHEMBL18413510 0.73 CNR2 (0.53) CYP11B1CYP11B2CNR2
SCHEMBL9662907 0.72 CCNT1 (0.46) CYP2B6CYP19A1TBXAS1CYP11B1CYP11B2
SCHEMBL9524167 0.70 S1PR1 (0.44) CYP2B6CYP19A1TBXAS1CYP11B1CYP11B2
SCHEMBL9665018 0.70 CYP19A1 (0.44) CYP2B6CYP19A1TBXAS1CYP11B1CYP11B2
SCHEMBL9663766 0.69 CYP11B1 (0.44) CYP19A1TBXAS1CYP11B1CYP11B2CYP17A1
SCHEMBL9664756 0.65 CYP19A1 (0.54) CYP2B6CYP19A1TBXAS1CYP11B1CYP11B2
SCHEMBL570574 0.65 CYP2B6 (1.00) CYP2B6CYP19A1TBXAS1
SCHEMBL20076324 0.65 CYP2B6 (1.00) CYP2B6CYP19A1TBXAS1
SCHEMBL11047040 0.65 CYP2B6 (1.00) CYP2B6CYP19A1TBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0260744-B1 (1H-IMIDAZOL-1-YLMETHYL) SUBSTITUTED BENZIMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1992-12-16 EP disclosed
US-4859684-A (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use thereof in treating androgen dependent disorders JANSSEN PHARMACEUTICA N.V. (BE) 1989-08-22 US disclosed
EP-0260744-A2 (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1988-03-23 EP disclosed